← quant terminal / congress tracker
Richard Blumenthal
Disclosed transactions, newest first. Amounts are STOCK Act range midpoints; disclosures lag actual trades by up to 45 days.
2026-09-23
SELL
STLNStarling Oncology, Inc. - Common Stock
$1,001–$15,000
2026-09-22
SELL
STLNStarling Oncology, Inc. - Common Stock
$1,001–$15,000
2026-09-22
SELL
STLNStarling Oncology, Inc. - Common Stock
$15,001–$50,000
2026-09-18
SELL
STLNStarling Oncology, Inc. - Common Stock
$1,001–$15,000
2026-09-18
SELL
STLNStarling Oncology, Inc. - Common Stock
$15,001–$50,000